Millennium Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$254M Sell
275,989
-58,869
-18% -$59.7M 0.11% 165
2025
Q4
$360M Buy
334,858
+34,601
+12% +$33.1M 0.15% 90
2025
Q3
$229M Sell
300,257
-270,635
-47% -$201M 0.1% 164
2025
Q2
$445M Sell
570,892
-110,121
-16% -$85.6M 0.21% 51
2025
Q1
$562M Sell
681,013
-120,052
-15% -$99.9M 0.3% 35
2024
Q4
$618M Sell
801,065
-189,144
-19% -$157M 0.3% 40
2024
Q3
$877M Buy
990,209
+458,171
+86% +$412M 0.42% 26
2024
Q2
$482M Sell
532,038
-292,285
-35% -$234M 0.22% 54
2024
Q1
$641M Buy
824,323
+69,615
+9% +$49.5M 0.27% 42
2023
Q4
$440M Sell
754,708
-159,110
-17% -$92.9M 0.19% 55
2023
Q3
$491M Buy
913,818
+95,130
+12% +$49M 0.25% 44
2023
Q2
$384M Buy
818,688
+815,226
+23,548% +$342M 0.19% 49
2023
Q1
$1.19M Sell
3,462
-73,828
-96% -$24.9M ﹤0.01% 3931
2022
Q4
$28.3M Sell
77,290
-261,319
-77% -$92.7M 0.02% 1165
2022
Q3
$109M Sell
338,609
-588,486
-63% -$186M 0.06% 286
2022
Q2
$301M Buy
927,095
+527,177
+132% +$158M 0.19% 45
2022
Q1
$115M Sell
399,918
-150,187
-27% -$38.7M 0.06% 287
2021
Q4
$152M Buy
550,105
+162,429
+42% +$41.2M 0.08% 211
2021
Q3
$89.6M Buy
387,676
+257,044
+197% +$63.4M 0.05% 354
2021
Q2
$30M Sell
130,632
-19,505
-13% -$3.92M 0.02% 897
2021
Q1
$28M Sell
150,137
-1,048,442
-87% -$205M 0.02% 839
2020
Q4
$202M Buy
1,198,579
+148,398
+14% +$22.2M 0.15% 92
2020
Q3
$155K Buy
1,050,181
+834,266
+386% +$129M 0.19% 69
2020
Q2
$35.4M Buy
215,915
+196,369
+1,005% +$30.1M 0.05% 445
2020
Q1
$2.71M Sell
19,546
-267,023
-93% -$36.7M 0.01% 1789
2019
Q4
$37.7M Buy
286,569
+209,412
+271% +$24.3M 0.05% 499
2019
Q3
$8.63M Sell
77,157
-145,835
-65% -$16.2M 0.01% 1382
2019
Q2
$24.7M Sell
222,992
-391,238
-64% -$46.1M 0.04% 664
2019
Q1
$79.7M Sell
614,230
-885,389
-59% -$108M 0.12% 198
2018
Q4
$174M Buy
1,499,619
+697,472
+87% +$77.9M 0.27% 58
2018
Q3
$86.1M Buy
802,147
+10,907
+1% +$1.09M 0.11% 231
2018
Q2
$67.5M Sell
791,240
-282,255
-26% -$23.2M 0.09% 285
2018
Q1
$83.1M Buy
1,073,495
+202,294
+23% +$16.3M 0.11% 241
2017
Q4
$73.6M Buy
871,201
+684,795
+367% +$58.3M 0.1% 247
2017
Q3
$15.9M Buy
+186,406
New +$15.3M 0.02% 928
2017
Q2
Sell
-65,634
Closed -$5.52M 3680
2017
Q1
$5.52M Sell
65,634
-15,262
-19% -$1.22M 0.01% 1398
2016
Q4
$5.95M Sell
80,896
-108,464
-57% -$8.08M 0.01% 1217
2016
Q3
$15.2M Sell
189,360
-586,502
-76% -$46.9M 0.03% 705
2016
Q2
$61.1M Sell
775,862
-116,529
-13% -$8.77M 0.14% 152
2016
Q1
$64.3M Buy
892,391
+536,342
+151% +$40.6M 0.16% 132
2015
Q4
$30M Sell
356,049
-145,568
-29% -$12.1M 0.06% 422
2015
Q3
$42M Buy
+501,617
New +$42.3M 0.08% 286
2015
Q2
Sell
-445,447
Closed -$33.9M 3604
2015
Q1
$32.4M Sell
445,447
-26,101
-6% -$1.86M 0.06% 420
2014
Q4
$32.5M Buy
471,548
+471,544
+11,788,600% +$31.8M 0.07% 378
2014
Q3
$0 Sell
4
-40,096
-100% -$2.54M ﹤0.01% 3865
2014
Q2
$2.49M Sell
40,100
-21,528
-35% -$1.28M 0.01% 1628
2014
Q1
$3.63M Sell
61,628
-451,372
-88% -$25.2M 0.01% 1395
2013
Q4
$26.2M Sell
513,000
-79,514
-13% -$3.98M 0.08% 254
2013
Q3
$29.8M Sell
592,514
-667,962
-53% -$35M 0.1% 209
2013
Q2
$61.9M Buy
+1,260,476
New +$68.6M 0.19% 53

Other funds holding LLY

Millennium Management's LLY Position: Q1 2026 in Review

Millennium Management reduced its Eli Lilly (LLY) stake by 18% in Q1 2026, selling an estimated $59.7M and leaving 275,989 shares worth $254M. The position accounts for 0.11% of the portfolio, ranked #165.

Millennium Management first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. The position peaked at $877M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Millennium Management held 275,989 shares of Eli Lilly worth $254M as of Q1 2026.
  • Millennium Management sold 58,869 Eli Lilly shares in Q1 2026, an estimated $59.7M.
  • Eli Lilly made up 0.11% of Millennium Management's portfolio in Q1 2026, its #165 holding.
  • Millennium Management first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
  • Millennium Management's Eli Lilly position peaked at $877M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.